Outset Medical, Inc. (OM): R&D Expense
$21.23M
Year ended 2025-12-31
$21.50M
Trailing 12 months to 2026-06-30
-24.3%
3-year compound annual growth
-5.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.23M | -44.7% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $38.40M | -33.0% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $57.31M | +17.3% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $48.85M | +33.0% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $36.74M | +27.4% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $28.85M | +23.7% | 2023-02-13, From 2020-01-01 |
| 2019-12-31 | $23.33M | +1.8% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $22.92M | n/a | 2021-03-22, From 2018-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Outset Medical, Inc. (OM) | 2025-12-31 | $21.23M | -44.7% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $7.57M | +59.3% |
| Vaso Corp (VASO) | 2025-12-31 | $728.0K | -14.5% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $19.14M | +41.2% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.31M | +31.9% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $32.88M | +18.4% |
| Iridex Corp (IRIX) | 2026-01-03 | $3.67M | -32.7% |
| InMode Ltd. (INMD) | 2025-12-31 | $13.32M | +1.4% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $9.38M | -3.9% |
Compare OM, BLFS, VASO, CBLL side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗